Inspire Medical Systems, Inc. (FRA:2DR)

Market Cap	1.44B -73.8%
Revenue (ttm)	776.73M +13.6%
Net Income	123.86M +171.8%
EPS	4.16 +179.4%
Shares Out	n/a
PE Ratio	11.66
Forward PE	28.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	4
Open	50.18
Previous Close	50.52
Day's Range	49.63 - 50.18
52-Week Range	46.52 - 185.35
Beta	n/a
RSI	32.04
Earnings Date	Feb 11, 2026

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open ai...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2007
• Employees: 1,333
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2DR

Financial Performance

In 2025, Inspire Medical Systems's revenue was $911.98 million, an increase of 13.60% compared to the previous year's $802.80 million. Earnings were $145.42 million, an increase of 171.77%.

Financial numbers in USD